CN Stock MarketDetailed Quotes

000919 Jinling Pharmaceutical

Watchlist
  • 6.26
  • -0.01-0.16%
Market Closed Jun 28 15:00 CST
3.94BMarket Cap39.62P/E (TTM)

Jinling Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
5.36%746.53M
4.30%2.79B
2.45%2.1B
6.60%1.44B
2.24%708.53M
-4.91%2.67B
-2.71%2.05B
-4.92%1.35B
-1.22%693.02M
12.18%2.81B
Operating revenue
5.36%746.53M
4.30%2.79B
2.45%2.1B
6.60%1.44B
2.24%708.53M
-4.91%2.67B
-2.71%2.05B
-4.92%1.35B
-1.22%693.02M
12.18%2.81B
Other operating revenue
----
30.19%28.83M
----
20.92%11.55M
----
12.86%22.15M
----
20.43%9.55M
----
10.09%19.62M
Total operating cost
4.09%686.04M
3.69%2.7B
2.64%2B
6.88%1.35B
4.32%659.05M
-0.80%2.6B
-0.41%1.95B
-2.35%1.26B
-1.21%631.77M
13.08%2.62B
Operating cost
3.10%576.63M
2.65%2.2B
2.23%1.65B
6.32%1.13B
4.14%559.31M
-1.65%2.14B
-0.35%1.62B
-2.73%1.06B
-1.62%537.06M
12.17%2.18B
Operating tax surcharges
4.93%4.3M
-4.05%18.62M
-3.78%13.28M
-4.89%8.89M
-12.94%4.1M
-2.35%19.41M
4.21%13.8M
9.13%9.35M
9.71%4.7M
22.46%19.87M
Operating expense
-20.89%6.81M
0.19%86.17M
10.54%64.38M
8.76%33.84M
-14.59%8.61M
-13.41%86M
9.05%58.24M
-11.50%31.12M
6.18%10.08M
55.68%99.32M
Administration expense
5.63%80.91M
12.85%335.7M
6.70%239.35M
9.45%162.22M
3.02%76.59M
4.38%297.48M
-5.05%224.32M
2.49%148.21M
0.29%74.35M
7.70%284.99M
Financial expense
10.40%-3.39M
-17.24%-22.55M
-18.14%-15.8M
-63.33%-9.87M
3.82%-3.78M
-6.01%-19.23M
-12.41%-13.37M
21.00%-6.04M
-215.00%-3.93M
-48.14%-18.14M
-Interest expense (Financial expense)
67.38%21.93K
-9.67%230.96K
3.42%141.82K
-1.97%98.07K
-84.12%13.1K
-12.63%255.67K
95.79%137.13K
42.84%100.05K
--82.51K
-23.70%292.63K
-Interest Income (Financial expense)
16.63%-3.55M
-19.13%-23.9M
-21.44%-16.97M
-67.18%-10.78M
-2.17%-4.25M
-5.05%-20.06M
-12.16%-13.98M
19.55%-6.45M
-185.35%-4.16M
-44.35%-19.1M
Research and development
45.99%20.78M
6.71%79.14M
-6.58%42.19M
37.49%27.63M
49.55%14.23M
30.09%74.17M
14.78%45.17M
-11.49%20.1M
37.13%9.52M
30.44%57.01M
Credit Impairment Loss
-203.96%-3.97M
34.71%-1.61M
-314.11%-7M
-413.27%-4.03M
12.72%-1.31M
-371.42%-2.46M
-189.98%-1.69M
-155.54%-784.51K
-2,230.60%-1.5M
116.51%907.84K
Asset Impairment Loss
----
-182.64%-337.47K
-198.05%-620.21K
---690.44K
----
100.85%408.36K
53,647.96%632.56K
----
----
3.26%-47.87M
Other net revenue
-95.39%449.46K
-53.14%27.97M
-12.43%17.48M
340.73%9.47M
252.55%9.76M
487.98%59.69M
1,149.73%19.96M
26.67%-3.94M
-13.05%-6.4M
116.92%10.15M
Fair value change income
113.89%1.52M
91.70%-2.25M
102.49%426.16K
98.37%-218.87K
109.82%710.75K
9.36%-27.14M
35.28%-17.11M
23.32%-13.42M
38.18%-7.24M
39.88%-29.95M
Invest income
-39.68%1.14M
26.66%18.9M
43.77%15.46M
18.86%6.61M
112.49%1.89M
-45.36%14.92M
-54.02%10.75M
-43.98%5.56M
-83.63%890.56K
-24.29%27.3M
-Including: Investment income associates
-47.68%990.1K
95.65%8.47M
-30.69%3.76M
112.20%3.08M
112.49%1.89M
267.28%4.33M
2,197.54%5.42M
-49.43%1.45M
2.65%890.56K
-124.06%-2.59M
Asset deal income
---42.82K
-100.16%-97.45K
-100.40%-78.49K
83.00%-37.54K
----
20.40%62.58M
5,384.85%19.6M
39.02%-220.86K
-385.27%-218.47K
29,787.21%51.98M
Other revenue
-78.70%1.8M
17.36%13.37M
19.41%9.29M
59.09%7.84M
407.63%8.46M
46.43%11.39M
147.86%7.78M
327.90%4.93M
131.72%1.67M
-8.94%7.78M
Operating profit
2.87%60.94M
-10.01%117M
-2.69%123.36M
18.61%99.19M
8.00%59.24M
-34.06%130.01M
-19.56%126.77M
-31.35%83.62M
-2.80%54.85M
57.38%197.17M
Add:Non operating Income
8.74%214.95K
44.62%2.83M
-51.87%932.07K
-26.28%427.93K
-33.13%197.67K
-11.63%1.96M
56.70%1.94M
13.41%580.48K
-19.26%295.6K
-19.01%2.22M
Less:Non operating expense
-99.86%637.72
-66.45%1.41M
-45.39%700.76K
-30.51%592.37K
-36.57%457.46K
-8.18%4.2M
-22.97%1.28M
3.20%852.51K
-23.26%721.2K
58.35%4.58M
Total profit
3.69%61.16M
-7.32%118.42M
-3.01%123.59M
18.80%99.02M
8.37%58.98M
-34.41%127.77M
-18.92%127.43M
-31.40%83.35M
-2.56%54.42M
55.69%194.81M
Less:Income tax cost
44.89%13.99M
-19.20%11.23M
-24.25%16.68M
-7.20%14.08M
-3.26%9.65M
-66.80%13.9M
-36.00%22.02M
-45.06%15.17M
-24.89%9.98M
33.07%41.88M
Net profit
-4.38%47.17M
-5.87%107.19M
1.43%106.91M
24.59%84.95M
10.98%49.33M
-25.55%113.87M
-14.13%105.41M
-27.38%68.18M
4.41%44.44M
63.29%152.94M
Net profit from continuing operation
-4.38%47.17M
-5.87%107.19M
1.43%106.91M
24.59%84.95M
10.98%49.33M
-25.55%113.87M
-14.13%105.41M
-27.38%68.18M
4.41%44.44M
63.29%152.94M
Less:Minority Profit
-36.89%3.62M
-12.23%7.53M
-25.36%9.3M
-17.24%7.42M
10.31%5.74M
-73.43%8.58M
-50.63%12.46M
-49.98%8.97M
-31.24%5.2M
13.28%32.31M
Net profit of parent company owners
-0.09%43.54M
-5.35%99.65M
5.02%97.61M
30.93%77.52M
11.07%43.59M
-12.72%105.28M
-4.69%92.95M
-22.05%59.21M
12.12%39.24M
85.19%120.63M
Earning per share
Basic earning per share
-1.85%0.0849
-5.36%0.1977
6.08%0.1937
32.02%0.1538
12.48%0.0865
-12.70%0.2089
-5.63%0.1826
-22.69%0.1165
10.81%0.0769
85.22%0.2393
Diluted earning per share
-1.85%0.0849
-5.36%0.1977
6.08%0.1937
32.02%0.1538
12.48%0.0865
-12.70%0.2089
-5.63%0.1826
-22.69%0.1165
10.81%0.0769
85.22%0.2393
Other composite income
12.55M
14.16M
14.16M
Other composite income of parent company owners
----
----
----
----
----
--12.55M
--14.16M
--14.16M
----
----
Total composite income
-4.38%47.17M
-15.21%107.19M
-10.59%106.91M
3.16%84.95M
10.98%49.33M
-17.34%126.41M
-2.60%119.57M
-12.30%82.34M
4.41%44.44M
63.29%152.94M
Total composite income of parent company owners
-0.09%43.54M
-15.43%99.65M
-8.87%97.61M
5.65%77.52M
11.07%43.59M
-2.32%117.83M
9.84%107.11M
-3.40%73.37M
12.12%39.24M
85.19%120.63M
Total composite income of minority owners
-36.89%3.62M
-12.23%7.53M
-25.36%9.3M
-17.24%7.42M
10.31%5.74M
-73.43%8.58M
-50.63%12.46M
-49.98%8.97M
-31.24%5.2M
13.28%32.31M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
--
--
--
Tianheng Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 5.36%746.53M4.30%2.79B2.45%2.1B6.60%1.44B2.24%708.53M-4.91%2.67B-2.71%2.05B-4.92%1.35B-1.22%693.02M12.18%2.81B
Operating revenue 5.36%746.53M4.30%2.79B2.45%2.1B6.60%1.44B2.24%708.53M-4.91%2.67B-2.71%2.05B-4.92%1.35B-1.22%693.02M12.18%2.81B
Other operating revenue ----30.19%28.83M----20.92%11.55M----12.86%22.15M----20.43%9.55M----10.09%19.62M
Total operating cost 4.09%686.04M3.69%2.7B2.64%2B6.88%1.35B4.32%659.05M-0.80%2.6B-0.41%1.95B-2.35%1.26B-1.21%631.77M13.08%2.62B
Operating cost 3.10%576.63M2.65%2.2B2.23%1.65B6.32%1.13B4.14%559.31M-1.65%2.14B-0.35%1.62B-2.73%1.06B-1.62%537.06M12.17%2.18B
Operating tax surcharges 4.93%4.3M-4.05%18.62M-3.78%13.28M-4.89%8.89M-12.94%4.1M-2.35%19.41M4.21%13.8M9.13%9.35M9.71%4.7M22.46%19.87M
Operating expense -20.89%6.81M0.19%86.17M10.54%64.38M8.76%33.84M-14.59%8.61M-13.41%86M9.05%58.24M-11.50%31.12M6.18%10.08M55.68%99.32M
Administration expense 5.63%80.91M12.85%335.7M6.70%239.35M9.45%162.22M3.02%76.59M4.38%297.48M-5.05%224.32M2.49%148.21M0.29%74.35M7.70%284.99M
Financial expense 10.40%-3.39M-17.24%-22.55M-18.14%-15.8M-63.33%-9.87M3.82%-3.78M-6.01%-19.23M-12.41%-13.37M21.00%-6.04M-215.00%-3.93M-48.14%-18.14M
-Interest expense (Financial expense) 67.38%21.93K-9.67%230.96K3.42%141.82K-1.97%98.07K-84.12%13.1K-12.63%255.67K95.79%137.13K42.84%100.05K--82.51K-23.70%292.63K
-Interest Income (Financial expense) 16.63%-3.55M-19.13%-23.9M-21.44%-16.97M-67.18%-10.78M-2.17%-4.25M-5.05%-20.06M-12.16%-13.98M19.55%-6.45M-185.35%-4.16M-44.35%-19.1M
Research and development 45.99%20.78M6.71%79.14M-6.58%42.19M37.49%27.63M49.55%14.23M30.09%74.17M14.78%45.17M-11.49%20.1M37.13%9.52M30.44%57.01M
Credit Impairment Loss -203.96%-3.97M34.71%-1.61M-314.11%-7M-413.27%-4.03M12.72%-1.31M-371.42%-2.46M-189.98%-1.69M-155.54%-784.51K-2,230.60%-1.5M116.51%907.84K
Asset Impairment Loss -----182.64%-337.47K-198.05%-620.21K---690.44K----100.85%408.36K53,647.96%632.56K--------3.26%-47.87M
Other net revenue -95.39%449.46K-53.14%27.97M-12.43%17.48M340.73%9.47M252.55%9.76M487.98%59.69M1,149.73%19.96M26.67%-3.94M-13.05%-6.4M116.92%10.15M
Fair value change income 113.89%1.52M91.70%-2.25M102.49%426.16K98.37%-218.87K109.82%710.75K9.36%-27.14M35.28%-17.11M23.32%-13.42M38.18%-7.24M39.88%-29.95M
Invest income -39.68%1.14M26.66%18.9M43.77%15.46M18.86%6.61M112.49%1.89M-45.36%14.92M-54.02%10.75M-43.98%5.56M-83.63%890.56K-24.29%27.3M
-Including: Investment income associates -47.68%990.1K95.65%8.47M-30.69%3.76M112.20%3.08M112.49%1.89M267.28%4.33M2,197.54%5.42M-49.43%1.45M2.65%890.56K-124.06%-2.59M
Asset deal income ---42.82K-100.16%-97.45K-100.40%-78.49K83.00%-37.54K----20.40%62.58M5,384.85%19.6M39.02%-220.86K-385.27%-218.47K29,787.21%51.98M
Other revenue -78.70%1.8M17.36%13.37M19.41%9.29M59.09%7.84M407.63%8.46M46.43%11.39M147.86%7.78M327.90%4.93M131.72%1.67M-8.94%7.78M
Operating profit 2.87%60.94M-10.01%117M-2.69%123.36M18.61%99.19M8.00%59.24M-34.06%130.01M-19.56%126.77M-31.35%83.62M-2.80%54.85M57.38%197.17M
Add:Non operating Income 8.74%214.95K44.62%2.83M-51.87%932.07K-26.28%427.93K-33.13%197.67K-11.63%1.96M56.70%1.94M13.41%580.48K-19.26%295.6K-19.01%2.22M
Less:Non operating expense -99.86%637.72-66.45%1.41M-45.39%700.76K-30.51%592.37K-36.57%457.46K-8.18%4.2M-22.97%1.28M3.20%852.51K-23.26%721.2K58.35%4.58M
Total profit 3.69%61.16M-7.32%118.42M-3.01%123.59M18.80%99.02M8.37%58.98M-34.41%127.77M-18.92%127.43M-31.40%83.35M-2.56%54.42M55.69%194.81M
Less:Income tax cost 44.89%13.99M-19.20%11.23M-24.25%16.68M-7.20%14.08M-3.26%9.65M-66.80%13.9M-36.00%22.02M-45.06%15.17M-24.89%9.98M33.07%41.88M
Net profit -4.38%47.17M-5.87%107.19M1.43%106.91M24.59%84.95M10.98%49.33M-25.55%113.87M-14.13%105.41M-27.38%68.18M4.41%44.44M63.29%152.94M
Net profit from continuing operation -4.38%47.17M-5.87%107.19M1.43%106.91M24.59%84.95M10.98%49.33M-25.55%113.87M-14.13%105.41M-27.38%68.18M4.41%44.44M63.29%152.94M
Less:Minority Profit -36.89%3.62M-12.23%7.53M-25.36%9.3M-17.24%7.42M10.31%5.74M-73.43%8.58M-50.63%12.46M-49.98%8.97M-31.24%5.2M13.28%32.31M
Net profit of parent company owners -0.09%43.54M-5.35%99.65M5.02%97.61M30.93%77.52M11.07%43.59M-12.72%105.28M-4.69%92.95M-22.05%59.21M12.12%39.24M85.19%120.63M
Earning per share
Basic earning per share -1.85%0.0849-5.36%0.19776.08%0.193732.02%0.153812.48%0.0865-12.70%0.2089-5.63%0.1826-22.69%0.116510.81%0.076985.22%0.2393
Diluted earning per share -1.85%0.0849-5.36%0.19776.08%0.193732.02%0.153812.48%0.0865-12.70%0.2089-5.63%0.1826-22.69%0.116510.81%0.076985.22%0.2393
Other composite income 12.55M14.16M14.16M
Other composite income of parent company owners ----------------------12.55M--14.16M--14.16M--------
Total composite income -4.38%47.17M-15.21%107.19M-10.59%106.91M3.16%84.95M10.98%49.33M-17.34%126.41M-2.60%119.57M-12.30%82.34M4.41%44.44M63.29%152.94M
Total composite income of parent company owners -0.09%43.54M-15.43%99.65M-8.87%97.61M5.65%77.52M11.07%43.59M-2.32%117.83M9.84%107.11M-3.40%73.37M12.12%39.24M85.19%120.63M
Total composite income of minority owners -36.89%3.62M-12.23%7.53M-25.36%9.3M-17.24%7.42M10.31%5.74M-73.43%8.58M-50.63%12.46M-49.98%8.97M-31.24%5.2M13.28%32.31M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianheng Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)------Tianheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg